FDA Approves Amgen And Allergan’s Kanjinti Trastuzumab Biosimilar

 
• By Dave Wallace

Amgen and Allergan’s biosimilar version of Herceptin has been approved by the US Food and Drug Administration.

FDA
The FDA has approved Amgen and Allergan’s Trastuzumab biosimilar • Source: Shutterstock

More from Biosimilars

More from Products